Home » Newsletters » BioWorld

BioWorld

Aug. 17, 2015

View Archived Issues

Money Raised By Biotech: 2015 vs. 2014

Increase in FDA approvals tied to fail fast and cheaply

Money Raised By Biotech: Jan 1 - Aug. 13, 2015

Week in Review

Week in Washington

Word on the street

FDA approvals in July

Phase I clinical trials update: July 2015

Phase II clinical trials update: July 2015

Phase III clinical trials update: July 2015

Alzheimer's association international conference July 2015

Pharma clinical and FDA action update: July 2015

Non-U.S. clinical trials and regulatory actions: July 2015

FDA submissions, approvals & other actions: July 2015

The Week's Biggest Gainers and Losers

BioWorld Stock Index

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...